Last Updated on October 2, 2024 by The Health Master
Nagpur: Clinical trials of a new BCG vaccine for tuberculosis (TB) will begin soon in India, according to Dr Shekhar Mande, former director-general of the Council for Scientific and Industrial Research (CSIR). He was speaking at the ongoing Indian Science Congress here.
Earlier in the day, Dr. Mande gave a presentation on ‘Biophysical Methods in Tuberculosis Research‘ and spoke about how technology has helped doctors and researchers understand TB better, paving ways to combat the infectious disease.
The CSIR is working towards rapid diagnosis, vaccination, and treatment to eliminate the bacterial disease from India by 2025, as envisioned by the government, he said, speaking to reporters later.
“We are mainly focusing on new medicines and drugs for tuberculosis.” We are doing background work and setting targets on research for prevention of tuberculosis,” he said
The National Institute of Tuberculosis Research, Chennai, will start clinical trials of the new BCG vaccine for TB, he said. The Bacillus Calmette-Guerin (BCG) vaccine is primarily used against tuberculosis.
According to the India TB Report 2022, the number of ‘incident TB patients’ (new and relapse cases) notified during 2021 stood at 19.3 lakh. On the government’s aim to make India TB-free by 2025.
Dr. Mande said, “There is a very serious effort going across various agencies in the country.” “The departments of health research, biotechnologies, and the CSIR are all working toward TB-free 2025.”
The goal is a huge challenge as the TB load in India is extremely high, he said. “It is anticipated that about 30 percent of the population is already infected with Mycobacterium tuberculosis (the bacterium that causes TB).
But the good news is that about 90 per cent of that 30 per cent will never ever develop TB in their lifetime. And only 10 per cent of those 30 per cent would develop TB at some point in time.”
The objective is to suppress even those 10 percent. “So, by 2025, we will actually be able to control that particular population and make India TB-free,” he said. There are multiple ways to achieve the goal, he said.
“For example, one of the most promising ways of controlling tuberculosis is something called DOTS therapy (directly observed treatment, short-course), in which the patient takes medicine in the presence of a doctor and the therapy is continued for 6 to 8 months and completed as best as possible,” Dr. Mande explained.
Notifications: New Drugs, FDC, Clinical Trial
Other details about New Drugs, FDCs, Clinical trial
FAQs by CDSCO on Pharma, Cosmetics, MDR, Clinical Trial
Drug licences of these two firms suspended: FDA Manipur
Fake pharma firm busted, two arrested
USFDA approves Fesoterodine Fumarate Extended-Release tablets
Medical Device alert: CDSCO issues medical device alert on MitraClip Clip Delivery System
Drug recall: Vancomycin Hydrochloride Injection recalled due to this reason
NPPA is in the process of fixing ceiling prices of 63 formulations
List of approved New Drugs Updated
No need to recall, re-label the drug for price revision if…….:NPPA
Registration for sale of Medical Devices: Procedure and conditions
Latest Notifications regarding Pharmaceuticals
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
